AtriCure to Present at ThinkEquity Partners 5th Annual Growth ... ( WEST CHESTER Ohio Sept. 12 /- Atr...)

AtriCure to Present at ThinkEquity Partners 5th Annual Growth Conference

Date:9/12/2007

WEST CHESTER, Ohio, Sept. 12 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company focused on developing, manufacturing and selling innovative cardiac surgical devices, announced today that David J. Drachman, President and Chief Executive Officer, is scheduled to present at the ThinkEquity Partners 5th Annual Growth Conference at the St. Regis Hotel in San Francisco, California on Thursday, September 20, at 8:30 a.m. PT.

A live web cast and recording of the presentation will be available for 30 days following the presentation on AtriCure's Investor Relations page at http://www.atricure.com.

About AtriCure, Inc.

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative cardiac surgical devices designed to create precise lesions, or scars, in cardiac, or heart, tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure Isolator(R) bipolar ablation clamps as a treatment alternative during open-heart surgical procedures to create lesions in cardiac tissue to block the abnormal electrical impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering of the upper chambers of the heart. Additionally, leading cardiothoracic surgeons have described the AtriCure Isolator(R) clamps as a promising treatment alternative for patients who may be candidates for sole-therapy minimally invasive procedures. AF affects more than 2.5 million Americans and predisposes them to a five-fold increased risk of stroke.

The FDA has cleared the AtriCure Isolator(R) bipolar ablation system, including the new Isolator Synergy(TM) ablation clam
'/>"/>

SOURCE AtriCure, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation

Post Your Comments:

(Date:12/1/2009)... , Recent Reviews In Majo...s One Of The Most Promising New Developments For T...utive Functioning Difficulties. Some Of The Most R... (PRWEB) December 1, 2009 -- Review written by: Le...isorders , Volume 13, No. 3 November 2009. A nice ...

(Date:12/1/2009)... , Anthony M. Marlon, MD ...c. (“Stemedica”) Board of Directors at... , (PRWEB) December 1, 200...medica Cell Technologies , Inc. (“Stemedica&...November 20th Board Meeting. Roger J. Howe, PhD, E...

(Date:12/1/2009)... , All Federal and Georgi...e hearing aid benefits. This new benefit is part o... drugs (MAPD) private fee for service (PFFS) Optio...d Healthcare and Kaiser Permanente. Atlanta Hearin...d in Dunwoody, GA Lake Oconee / Greensboro, GA and...

(Date:12/1/2009)... , , EAGAN, Minn., Dec. 1 ...pproach to health care for Blue Cross and Blue Shi...bers today, becoming the first Minnesotans - and t...to Online Care Anywhere(SM). Online Care Anywhere ...r work simply by logging onto a computer or pickin...

(Date:12/1/2009)... , , SEATTLE, Dec. 1 /PRNewswire-F... and MTA: CTIC) management,s presentation at the 2... Tuesday, December 1 at 11:00 a.m. Eastern Time wi... ,, The presentation will take place in Holmes...available for replay after the presentation. , ,...

Breaking Medicine News(10 mins):Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 2 Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 3 Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2 Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3 Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 2 Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 3 Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 4 Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2 Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3

[0] Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV [0] Prominent Health Care Executive Joins Stemedica Board Of Directors [0] Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 [0] Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM)[0] Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast

...nd LONDON, May 18 /PRNewswire/ -- Eularis is ann...harmaceutical eMarketing: Building Brands, Relatio..." The comprehensive report has been created to dem...hese emerging tools. , , "As market growth slow...

...and education come fewer chronic problems, study f...- People who are wealthy and educated appear to ha...r life. , Researchers from the British Economic &a...educated were less likely to have depression, high...

...la., May 18 When combined with a cocktail of chem... of one, appear to offer superior results in patie...ing to Mayo Clinic researchers working with th...at adding the targeted therapy epratuzumab to a re...

... data show olanzapine LAI safety findings consiste...ed events , , INDIANAPOLIS, May 18 Eli Lilly and...ng-term efficacy and safety of olanzapine long-act...ombines the atypical antipsychotic Zyprexa(R) (ola...

...y 18 Dr. Andree Bates, President of the Pharmaceu...g a MasterClass on how to tell if you are making t...aris, WHAT: MasterClass on the latest techniq...: 12 June 2009, WHERE: 1 Northumberland Aven...

...NS, N.Y., May 18 In a program that gives kids a c...termediate School in Eden Prairie, MN, raised an i... one of The Leukemia & Lymphoma Society,s Scho...ast year. The money will help fund LLS,s research ...

Eularis Releases Comprehensive Report on Effective and Measurable Pharmaceutical eMarketing Using Social Media Money May Matter, Health-Wise, in Old Age Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say Olanzapine Long-Acting Injection (LAI) Efficacy and Safety Data Presented at American Psychiatric Association Annual Meeting MEDIA ALERT - Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London One Little Penny...One Big Difference

(Date:11/30/2009)...e/ -- The Special Committee of Independent Directo...SX: PTI) and JLL Partners, Inc. and its affiliate,...today announced that the Company and JLL have ente...pending legal actions between the parties. ,,...,, until March 2011, the Board will consist of...

(Date:11/30/2009)...PRNewswire-FirstCall/ -- Henry Schein, Inc., (Nasd...roducts and services, announced today that Steven ...nd Chief Financial Officer, will present at the NA...r 1, 2009. The conference is taking place at the ...sentation is scheduled to begin at 9:15 a.m. EST a...

(Date:11/30/2009)... MedQuist Inc. (Nasdaq: ...linical documentation services, today announced th...ations, Inc. (Nuance) under which MedQuist will no...engine and processing software for use in SpeechQ ...ch recognition application for all medical discipl...

Breaking Medicine Technology:Patheon and JLL Partners Announce Litigation Settlement 2 Patheon and JLL Partners Announce Litigation Settlement 3 Henry Schein to Present at the NASDAQ OMX 23rd Investor Program 2 MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2 Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 1 Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 2 Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 3 Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care De 60679 4 Porter Novelli Wins Gold from Medical Marketing 26amp 3B Media for Best Unbranded TV Ad 60676 1 Porter Novelli Wins Gold from Medical Marketing 26amp 3B Media for Best Unbranded TV Ad 60676 2 Medicago to present at the U S Department of Health and Human Services Global Health Security Initiative Workshop 14720 1 Medicago to present at the U S Department of Health and Human Services Global Health Security Initiative Workshop 14720 2

[0] Patheon and JLL Partners Announce Litigation Settlement [0] Henry Schein to Present at the NASDAQ OMX 23rd Investor Program [0] MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties

...da Rosenberg, CEO of the International Partnership...on the results of the Phase II/IIb safety and effe...ent concentration): , , SILVER SPRING, Md., Feb. ...laborative group funded by the US National Institu... Phase II/IIb safety and effectiveness study of tw...

...SHVILLE, Tenn., Feb. 6 Christie Cookie is volunta...er Frozen Cookie Dough and,Devonshire Gourmet Pean...em,numbers 5507, 6607, 592263 and 502948 and a bes...e recall was initiated because these products cont...oration of America (PCA) in,Blakely, Georgia, and ...

Other Medicine Technology:New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide 2 New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide 3 New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide 4 Christie Cookie Recalls Certain Lots of Peanut Butter Cookie Dough Due to Expanded Recall by Peanut Corporation of America 2

New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide Christie Cookie Recalls Certain Lots of Peanut Butter Cookie Dough Due to Expanded Recall by Peanut Corporation of America

Xcluda Style C 960

ART Self-Sealing Barrier Tips, 30 l

...esistant Tips offer a safe alternative to using po...ed for applications such as PCR(a), pipetting radi..., ART Tips are excellent for tissue culture, gel l...RT Tips prevent aerosol contaminants and liquids f...

Xcluda Style B 960

Medicine Products:

Xcluda Style C 960 ART Self-Sealing Barrier Tips, 30 l ART 20P Pipet Tip, 20µl Xcluda Style B 960

AtriCure to Present at ThinkEquity Partners 5th Annual Growth ...( WEST CHESTER Ohio Sept. 12 /- Atr...),Health